Open AccessCombination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria
Author(s) -
Egidio Imbalzano,
Mirko Scarpelli,
Giuseppe Mandraffino,
Michele Creazzo,
G. Lizio,
Giovanni Di Trapani,
Giuseppe Dattilo,
Andrea Dalbeni,
C. Tomasello,
M.A. Sardo,
Antonino Saitta
Publication year - 2014
Publication title -
journal of the renin-angiotensin-aldosterone system
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 46
eISSN - 1752-8976
pISSN - 1470-3203
DOI - 10.1177/1470320314530018
Subject(s) - ramipril , losartan , medicine , microalbuminuria , aliskiren , blood pressure , urology , type 2 diabetes mellitus , combination therapy , ace inhibitor , diabetes mellitus , endocrinology , cardiology , angiotensin converting enzyme , angiotensin ii , renin–angiotensin system
The aim of this study was to assess the antihypertensive efficacy and safety of aliskiren versus ramipril or losartan in hypertensive patients with type 2 diabetes mellitus, microalbuminuria and uncontrolled hypertension, despite the use of optimal conventional antihypertensive therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom